Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
University of Ottawa and Institut du Savoir Montfort, Ottawa, Ontario, Canada.
Psychol Med. 2023 Nov;53(15):7242-7254. doi: 10.1017/S0033291723000788. Epub 2023 Apr 5.
Dynamic interpersonal therapy (DIT) is a brief, structured psychodynamic psychotherapy with demonstrated efficacy in treating major depressive disorder (MDD). The aim of the study was to determine whether DIT is an acceptable and efficacious treatment for MDD patients in China.
Patients were randomized to 16-week treatments with either DIT plus antidepressant medication (DIT + ADM; = 66), general supportive therapy plus antidepressant medication (GST + ADM; = 75) or antidepressant medication alone (ADM; = 70). The Hamilton Depression Rating Scale (HAMD) administered by blind raters was the primary efficacy measure. Assessments were completed during the acute 16-week treatment and up to 12-month posttreatment.
The group × time interaction was significant for the primary outcome HAMD ( = 2.900, df = 10, df = 774.72, = 0.001) in the acute treatment phase. Pairwise comparisons showed a benefit of DIT + ADM over ADM at weeks 12 [least-squares (LS) mean difference = -3.161, = 0.007] and 16 (LS mean difference = -3.237, = 0.004). Because of the unexpected high attrition during the posttreatment follow-up phase, analyses of follow-up data were considered exploratory. Differences between DIT + ADM and ADM remained significant at the 1-, 6-, and 12-month follow-up (s range from 0.001 to 0.027). DIT + ADM had no advantage over GST + ADM during the acute treatment phase. However, at the 12-month follow-up, patients who received DIT remained less depressed.
Acute treatment with DIT or GST in combination with ADM was similarly efficacious in reducing depressive symptoms and yielded a better outcome than ADM alone. DIT may provide MDD patients with long-term benefits in symptom improvement but results must be viewed with caution.
动态人际治疗(DIT)是一种简短、结构化的精神动力学心理疗法,已被证明对治疗重度抑郁症(MDD)有效。本研究旨在确定 DIT 是否是中国 MDD 患者可接受且有效的治疗方法。
患者被随机分配至 16 周的治疗组,分别接受 DIT 联合抗抑郁药物治疗(DIT+ADM,n=66)、一般支持性心理治疗联合抗抑郁药物治疗(GST+ADM,n=75)或单独抗抑郁药物治疗(ADM,n=70)。由盲评者进行的汉密尔顿抑郁量表(HAMD)评估是主要疗效指标。评估在急性 16 周治疗期间和治疗后 12 个月进行。
在急性治疗阶段,主要结局 HAMD 的组×时间交互作用具有统计学意义( = 2.900,df = 10,df = 774.72, = 0.001)。两两比较显示,在第 12 周[最小二乘法(LS)均数差=-3.161, = 0.007]和第 16 周[LS 均数差=-3.237, = 0.004],DIT+ADM 优于 ADM。由于治疗后随访阶段的高脱落率,对随访数据的分析被认为是探索性的。在 1、6 和 12 个月的随访中,DIT+ADM 与 ADM 之间的差异仍有统计学意义(s 范围为 0.001 至 0.027)。在急性治疗阶段,DIT+ADM 与 GST+ADM 之间没有优势。然而,在 12 个月的随访中,接受 DIT 的患者抑郁症状改善得更好。
DIT 或 GST 联合 ADM 治疗与单独使用 ADM 治疗急性 MDD 均能有效减轻抑郁症状,且疗效优于单独使用 ADM。DIT 可能会为 MDD 患者带来症状改善的长期获益,但结果必须谨慎看待。